NASDAQ : CYCN
Cyclerion Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 23.520007 USD (At close: Sep 8, 2026) · Market cap 15.48M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Cyclerion Therapeutics, Inc. (CYCN) reported revenue of 1.90M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 1.90M | 2.07M | 2.00M | 297.00K | 3.94M | |
| Cost of Revenue | 1.60M | 959.00K | 286.00K | 1.31M | 5.58M | 37.64M |
| Gross Profit | 303.00K | 1.11M | 1.71M | -1.31M | -5.28M | -33.69M |
| Selling, General & Admin | 7.13M | 6.09M | 5.34M | 8.33M | 13.26M | 20.62M |
| Operating Expenses | 7.13M | 6.09M | 5.34M | 8.33M | 13.26M | 20.62M |
| Operating Income | -6.82M | -4.97M | -3.63M | -9.65M | -18.54M | -54.31M |
| Interest Expense | -16.00K | |||||
| Interest & Investment Income | 117.00K | 128.00K | 208.00K | 358.00K | 294.00K | |
| Other Non Operating Income (Expenses) | 363.00K | |||||
| EBT Excluding Unusual Items | -6.71M | -4.84M | -3.06M | -9.29M | -18.25M | -54.33M |
| Asset Writedown | -3.30M | |||||
| Other Unusual Items | 2.68M | |||||
| Pretax Income | -6.71M | -3.53M | -3.06M | -12.59M | -18.25M | -51.65M |
| Earnings From Continuing Operations | -6.71M | -3.53M | -3.06M | -12.59M | -18.25M | -51.65M |
| Earnings From Discontinued Operations | 7.33M | -25.83M | ||||
| Net Income | -6.71M | -3.53M | -3.06M | -5.26M | -44.08M | -51.65M |
| Net Income to Common | -6.71M | -3.53M | -3.06M | -5.26M | -44.08M | -51.65M |
| Shares Outstanding (Basic) | 3.87M | 3.18M | 2.52M | 2.34M | 2.17M | 1.96M |
| Shares Outstanding (Diluted) | 3.87M | 3.18M | 2.52M | 2.34M | 2.17M | 1.96M |
| EPS (Basic) | -1.73 | -1.11 | -1.21 | -2.25 | -20.28 | -26.39 |
| EPS (Diluted) | -1.73 | -1.11 | -1.21 | -2.25 | -20.28 | -26.39 |
| Free Cash Flow | -4.52M | -3.31M | -4.33M | -21.25M | -40.61M | -36.52M |
| Free Cash Flow Per Share | -1.17 | -1.04 | -1.72 | -9.09 | -18.69 | -18.66 |
| Gross Margin | 15.95% | 53.76% | 85.70% | |||
| Operating Margin | -359.16% | -239.78% | -181.40% | -6,242.42% | -1,377.83% | |
| Profit Margin | -353.00% | -170.11% | -152.85% | -14,841.08% | -1,310.17% | |
| Free Cash Flow Margin | -237.74% | -159.79% | -216.65% | -13,673.74% | -926.53% | |
| EBITDA | -9.58M | -18.48M | -53.84M | |||
| D&A For EBITDA | 65.00K | 65.00K | 472.00K | |||
| EBIT | -6.82M | -4.97M | -3.63M | -9.65M | -18.54M | -54.31M |
| EBIT Margin | -239.78% | -181.40% | ||||
| Revenue as Reported | 1.90M | 2.07M | 2.00M | 297.00K | 3.94M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.39M | 3.24M | 3.23M | 7.57M | 13.38M | 53.96M |
| Cash & Short-Term Investments | 1.39M | 3.24M | 3.23M | 7.57M | 13.38M | 53.96M |
| Receivables | 1.00M | 556.00K | 96.00K | 100.00K | ||
| Prepaid Expenses | 112.00K | 384.00K | 421.00K | 442.00K | 805.00K | 928.00K |
| Other Current Assets | 11.00K | 11.00K | 16.00K | 11.00K | 537.00K | 468.00K |
| Total Current Assets | 1.51M | 4.63M | 4.22M | 8.02M | 14.82M | 55.46M |
| Property, Plant & Equipment | 66.00K | 1.22M | 1.47M | |||
| Long-Term Investments | 5.35M | 5.35M | 5.35M | 5.35M | ||
| Other Long-Term Assets | 2.04M | 2.41M | ||||
| Total Assets | 6.93M | 9.98M | 9.57M | 13.37M | 18.08M | 59.33M |
| Accounts Payable | 1.60M | 508.00K | 390.00K | 1.20M | 2.97M | 1.83M |
| Accrued Expenses | 182.00K | 354.00K | 305.00K | 775.00K | 4.59M | 8.73M |
| Other Current Liabilities | 64.00K | 38.00K | 30.00K | 113.00K | 68.00K | 526.00K |
| Total Current Liabilities | 1.84M | 900.00K | 725.00K | 2.09M | 7.63M | 11.09M |
| Total Liabilities | 1.84M | 900.00K | 725.00K | 2.09M | 7.63M | 11.09M |
| Additional Paid-In Capital | 281.04M | 280.11M | 276.34M | 275.72M | 269.63M | 263.35M |
| Retained Earnings | -275.95M | -271.02M | -267.49M | -264.42M | -259.15M | -215.08M |
| Comprehensive Income & Other | -12.00K | -20.00K | -23.00K | |||
| Shareholders' Equity | 5.09M | 9.09M | 8.85M | 11.29M | 10.45M | 48.25M |
| Total Liabilities & Equity | 6.93M | 9.98M | 9.57M | 13.37M | 18.08M | 59.33M |
| Net Cash (Debt) | 1.39M | 3.24M | 3.23M | 7.57M | 13.38M | 53.96M |
| Net Cash Per Share | 0.36 | 1.02 | 1.28 | 3.24 | 6.16 | 27.57 |
| Filing Date Shares Outstanding | 4.61M | 4.23M | 2.55M | 2.54M | 2.18M | 2.17M |
| Total Common Shares Outstanding | 4.26M | 3.82M | 2.55M | 2.47M | 2.18M | 2.17M |
| Working Capital | -329.00K | 3.73M | 3.50M | 5.94M | 7.19M | 44.37M |
| Book Value Per Share | 1.20 | 2.38 | 3.48 | 4.56 | 4.80 | 22.23 |
| Tangible Book Value | 5.09M | 9.09M | 8.85M | 11.29M | 10.45M | 48.25M |
| Tangible Book Value Per Share | 1.20 | 2.38 | 3.48 | 4.56 | 4.80 | 22.23 |
| Machinery | 51.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -6.71M | -3.53M | -3.06M | -5.26M | -44.08M | -51.65M |
| Depreciation & Amortization | 65.00K | 472.00K | ||||
| Loss (Gain) From Sale of Assets | 6.32M | |||||
| Asset Writedown & Restructuring Costs | 3.30M | |||||
| Stock-Based Compensation | 322.00K | 441.00K | 625.00K | 1.07M | 6.25M | 9.61M |
| Other Operating Activities | -363.00K | -2.68M | ||||
| Change in Accounts Receivable | 525.00K | -444.00K | -556.00K | 96.00K | 4.00K | 27.00K |
| Change in Accounts Payable | 1.14M | 118.00K | -445.00K | -1.77M | 1.14M | 393.00K |
| Change in Other Net Operating Assets | 274.00K | 99.00K | -537.00K | -2.92M | -4.00M | 988.00K |
| Operating Cash Flow | -4.45M | -3.31M | -4.33M | -21.25M | -40.61M | -36.52M |
| Capital Expenditures | -66.00K | -7.00K | ||||
| Sale of Property, Plant & Equipment | 1.46M | |||||
| Other Investing Activities | 10.40M | |||||
| Investing Cash Flow | -66.00K | 10.40M | 1.46M | |||
| Issuance of Common Stock | 2.90M | 3.45M | 1.98M | 29.00K | 30.79M | |
| Other Financing Activities | -130.00K | |||||
| Financing Cash Flow | 2.90M | 3.32M | 5.02M | 29.00K | 30.79M | |
| Foreign Exchange Rate Adjustments | -6.00K | 8.00K | 3.00K | 4.00K | ||
| Net Cash Flow | -1.61M | 8.00K | -4.34M | -5.81M | -40.58M | -4.27M |
| Free Cash Flow | -4.52M | -3.31M | -4.33M | -21.25M | -40.61M | -36.52M |
| Free Cash Flow Margin | -237.74% | -159.79% | -216.65% | -13,673.74% | -926.53% | |
| Free Cash Flow Per Share | -1.17 | -1.04 | -1.72 | -9.09 | -18.69 | -18.66 |
| Levered Free Cash Flow | -2.08M | -2.89M | -3.54M | -9.52M | -8.67M | -20.34M |
| Unlevered Free Cash Flow | -2.08M | -2.89M | -3.54M | -9.52M | -8.67M | -20.33M |
| Change in Working Capital | 1.93M | -227.00K | -1.54M | -4.60M | -2.85M | 1.41M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 15.48M | 4.83M | 8.15M | 8.19M | 28.54M | 74.50M |
| Enterprise Value | 14.09M | 265.89K | 5.28M | -916.93K | 8.14M | 15.51M |
| Last Close Price | 23.52 | 1.27 | 3.22 | 3.35 | 13.12 | 34.40 |
| PS Ratio | 8.15 | 2.33 | 4.08 | 96.10 | 18.90 | |
| PB Ratio | 2.81 | 0.53 | 0.92 | 0.73 | 2.73 | 1.54 |
| P/TBV Ratio | 3.04 | 0.53 | 0.92 | 0.73 | 2.73 | 1.54 |
| EV/Sales Ratio | 7.42 | 0.13 | 2.64 | 27.39 | 3.93 | |
| Net Debt / Equity Ratio | -0.27 | -0.36 | -0.36 | -0.67 | -1.28 | -1.12 |
| Net Debt / EBITDA Ratio | 0.79 | 0.72 | 1.00 | |||
| Net Debt / FCF Ratio | 0.31 | 0.98 | 0.75 | 0.36 | 0.33 | 1.48 |
| Asset Turnover | 0.23 | 0.21 | 0.17 | 0.01 | 0.04 | |
| Quick Ratio | 0.76 | 4.71 | 5.22 | 3.63 | 1.77 | 4.88 |
| Current Ratio | 0.82 | 5.15 | 5.83 | 3.85 | 1.94 | 5.00 |
| Return on Equity (ROE) | -98.22% | -39.34% | -30.36% | -115.85% | -62.17% | -95.87% |
| Return on Assets (ROA) | -52.33% | -31.78% | -19.76% | -38.34% | -29.94% | -38.86% |
| Return on Capital Employed (ROCE) | -134.10% | -54.70% | -41.00% | -85.50% | -177.40% | -112.60% |
| Earnings Yield | -43.33% | -72.98% | -37.51% | -64.25% | -154.44% | -69.32% |
| FCF Yield | -29.18% | -68.56% | -53.17% | -259.37% | -142.29% | -49.02% |
| Buyback Yield / Dilution | -44.12% | -26.33% | -7.70% | -7.59% | -11.03% | -28.75% |